Gwag T, Meng Z, Sui Y, Helsley RN, et al. Erratum to: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis [J Hepatol (2019); 70 (5): 930-940]. J Hepatol 2021 Jan 29. pii: S0168-8278(21)00003.
PMID: 33526292